Key result
An Enhanced Recovery After Surgery (ERAS) program for mini-invasive aortic valve replacement reduced median hospital length of stay compared to traditional care (7 vs 10 days; P<0.001).
Why the study?
Most studies evaluating Enhanced Recovery After Surgery (ERAS) programs have encompassed colorectal and orthopedic surgeries, leaving a need for evidence regarding its feasibility and effectiveness in mini-invasive aortic valve replacement.
Does an ERAS program reduce hospital length of stay and improve outcomes in patients undergoing mini-invasive aortic valve replacement?
Observational (n=46)
No
Does an ERAS program reduce hospital length of stay and improve outcomes in patients undergoing mini-invasive aortic valve replacement?
Absolute Event Rate: 7% vs 10%
p-value: p=<0.001
Implementing an ERAS program for mini-invasive aortic valve replacement is feasible and significantly reduces hospital length of stay and postoperative pain.
ERAS paired with robotic TECAB was associated with shorter stays and fewer transfusions; leaves open whether RCTs will confirm benefits before wider adoption.
OBJECTIVES: Presently, there is enthusiasm for the Enhanced Recovery After Surgery (ERAS) program. The literature clearly indicates this type of program could shorten hospital length of stay and improve patient outcome. However, most of the studies conducted have encompassed mainly colorectal and orthopedic surgeries. Thus, in an effort to provide more evidence to the literature, the authors prospectively investigated the feasibility and clinical effectiveness of a dedicated ERAS program for mini-invasive aortic valve replacements (MIAVRs). DESIGN: Observational before-and-after trial. SETTING: University hospital. PARTICIPANTS: Consecutive patients scheduled for an MIAVR via a mini-sternotomy during 2 time periods-before (MIAVR group) and after implementation of an ERAS program (MIAVR-ERAS group). INTERVENTIONS: Patients in the dedicated MIAVR-ERAS group followed a dedicated pathway specifically designed for this procedure, which encompasses several evidence-based medicine elements for cardiac surgery. MEASUREMENTS AND MAIN RESULTS: Data on patient demographics, patient characteristics, compliance to the ERAS protocol, postoperative morphine consumption, postoperative pain scores, postoperative complications, hospital length of stay, and hospital readmission rate were collected and compared. Twenty-three patients were enrolled in each group. Patients enrolled in the new protocol had significantly lower postoperative pain scores (p = 0.03). The median hospital length of stay was 10 (9-13.5) and 7 (6.5-8) days in the traditional MIAVR group and in the MIAVR-ERAS group, respectively (p < 0.001). CONCLUSIONS: An ERAS pathway planned for MIAVR seems feasible and was associated with a shorter length of hospital stay with trends toward both less opioid consumption and less postoperative complications.
No takes yet. Share an insight, caveat, or question.
Zaouter et al. (2019) conducted an observational in Mini-invasive aortic valve replacement (n=46). Enhanced Recovery After Surgery (ERAS) program vs. Traditional care (before ERAS implementation) was evaluated on Hospital length of stay (days) (p=<0.001). An Enhanced Recovery After Surgery (ERAS) program for mini-invasive aortic valve replacement reduced median hospital length of stay compared to traditional care (7 vs 10 days; P<0.001).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: